A Chronic Illness of Fatigue, Neurologic and Immunologic Disorders, & Active Human Herpesvirus Type 6 Infection
Ann Int Med 116:103-113, Buchwald,D.,et al, 1992
Neurogenic Dysphagia
JNNP 54:1037-1039, Wiles,C.M., 1991
Internal Capsule Plaque and Tonic Spasms in Multiple Sclerosis
Arch Neurol 48:427-429, Maimone,D.,et al, 1991
Convergence-Evoked Nystagmus
Neurol 40:161-162, Oliva,A.&Rosenberg,M.L., 1990
Seizures and Other Neurologic Sequelae of Bacterial Meningitis in Children
NEJM 323:1651-1657, Pomeroy,S.L.,et al, 1990
Chronic Central Nervous System Involvement in Lyme Borreliosis
Neurol 38:863-867, Kohler,J.,et al, 1988
Magnetic Resonance Imaging of the Central Nervous System Council on Scientific Affairs
Report of the Panel on MRI, JAMA 259:1211-12221988., , 1988
Results of the Seven-Year Prospective Study of Stroke Patients
Stroke 19:942-949, Scmidt,E.V.,et al, 1988
Tuberculous Meningitis:Role of CT in Management and Prognosis
JNNP 50:30-36, Kingsley,D.P.E.,et al, 1987
Segmental Myoclonus Clinical and Pharmacologic Study
Arch Neurol 43:1025-1031, Jankovic,J.&Pardo,R., 1986
Monosymptomatic Sensory Symptoms & Cerebrospinal Fluid Immunoglobulin Levels in Relation to Multiple Sclerosis
Arch Neurol 43:447-451, Kostulas,V.K.,et al, 1986
Clinicopathological Conference
Case 2-1984, Fabry's Disease, NEJM 310:106-114984., , 1984
Paroxysmal Dystonia as the Initial Manifestation of Multiple Sclerosis
Arch Neurol 41:747-750, Berger,J.R.,et al, 1984
Paroxysmal Limb Hemiataxia with Crossed Facial Paresthesias in Multiple Sclerosis
JAMA 250:2843-2844, Skillrud,D.M.,et al, 1983
The One- & -A-Half Syndrome-A Unilateral Disorder of the Pontine Tegmentum:A Study of 20 Cases & Review of the Liter
Neurol 33:971-980, Wall,M.,et al, 1983
Blepharospasm Associated with Brainstem Lesions
Neurol 33:1237-1240, Jankovic,J.,et al, 1983
Primary Position Upbeating Nystagmus:A Variety of Central Positional Nystagmus
Brain 106:949-964, Fisher,A.,et al, 1983
Clusters of Tonic Spasms as an Initial Manifestation of Multiple Sclerosis
Ann Neurol 12:494-495, Heath,P.D.,et al, 1982
Paroxysmal Symptoms as the First Manifestations of Multiple Sclerosis
JNNP 43:296-304, Twomey,J.A.,et al, 1980
Multiple Sclerosis & Narcopsy/cataplexy in a Monozygotic Twin
Neurol 30:105-108, Schrader,H.,et al, 1980
Bilateral Sixth Nerve Palsy
Arch Neurol 33:681, Keane,J.R., 1976
Isolated Facial Numbness
Ann Int Med 80:49, Horowitz,S., 1974
Bilateral Internuclear Ophthalmoplegia
Arch Neurol 31:168 1974., Goneyea,E., 1974
Central Vertigo
Otolaryn Clin North Am 6:267, Frederic,M., 1973
Narcolepsy
NEJM 288:1156, Zarcone,V., 1973
Multiple Sclerosis Associated with Defects in Neuromuscular Transmission
JNNP 35:385, Patten,B.M.,et al, 1972
Internuclear Ophthalmoplegia, Typical & Atypical
Arch Ophthal 84:583, Cogan,D.G., 1970
Frequency of AQP4 and MOG Antibodies in Patients with Optic Neuritis Fulfilling Minimal New Multiple Sclerosis MRI Criteria
Neurol 106:e214753, Deschamps,R.,et al, 2026
The 2024 McDonld Criteria for Dignosis of Multiple Sclerosis, The Rubber meets the Road
Neurol 106:e214688, Miller, A.E., 2026
Diagnostic Value of the Kappa Free light Chain Index to Distinguish MOGAD, NMOSD, and MS
Neurol 106:e214946, Tournier,A.,et al, 2026
Using Susceptibility-Based Imaging in highly ctive Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026
Myelitis-Predominant Agressive Phenotype:Unveiling Unique Paterns of Late-Onset Neuromyelitis Optica Spectrum Disorders
Ann Neurol 99:1139-1151, Pu,Y-L.,et al, 2026
Association of Changes in Activity Patterns with Brain Atrophy and Disability Progression in People with Multiple Sclerosis
Neurol 106:e214678, e214742, Fitzgerald,K.C.,et al, 2026
Using Susceptibility-Based Imaging in Highly Active Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026
A 32-Year-Old Woman with Progressive Vision Loss and Confusion
Neurol 106:e214988, Kumar,A.B.,et al, 2026
A 30-Year-Old Female Patient with Multiple Sclerosis Presenting with Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia
Neurol 105:e214429, Trentadue,T.,et al, 2025
Recurrent Ischemic Strokes Due to Os Odontoideum
Ann Neurol 98:1315-1317, Wang,J.,et al, 2025
Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025
Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025
A 60-Year-Old Man with Rapidly Progressive Left Hemibody Weakness and Vision Loss
Neurol 105: e213869, Rock,M.,et al, 2025
Clinicopathological Conference, Powasan Virus Encephalitis
NEJM 393:176-184, Case 19-2025, 2025
Collaboration on the Optimal Timing of Anticoagulation after Ischaemic Stroke and Atrial Fibrillation:A Systematic Review and Prospective Individual Participant Data Meta-Analysis of Randomised Controlled Trials (CATALYST)
Lancet 406:43-51, Dehbi,K-M.,et al, 2025
Powassan Virus Encephalitis: A Tertiary Center Experience
Clin Inf Dis 78:80-89, Mendoza,M.A.,et al, 2024
Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
Ann Neurol 96:846-854, Marrodan,M.,et al, 2024
Clinicopathologic Conference, Infective Endocarditis Due to Haemophilus Parainfluenza
NEJM 391:2148-2157, Case 38-2024, 2024
Slowly Expanding Lesions Differentiate Pediatric Multiple Sclerosis from Myelin Oligodendrocyte Glycoprotein Antibody Disease
Ann Neurol 96:1086-1091, Fadda,G.,et al, 2024
Decompressive Carniectomy Plus Best Medical Treatment Versus Best Medical Treatment Alone for Spontaneous Severe Deep Supratentorial Intracerebral Haemorrhage:A Randomised Controlled Clinical Trial
Lancet 403:2395-2404, Beck,J.,et al, 2024
Persistent Hypoglossal Artery and Simulateneous Antero-Posterior Circulation Strokes
Neurol 103:e209716, Kesav,P.,et al, 2024
Clinicopathologic Conference, Paraneoplastic Encephalomyelitis Due to Small-Cell Lung Carcinoma and Concurrent Cerebral Amyloid Angiopathy
NEJM< 391357-369, Case 23-2024, 2024
Adverse Events Associated with Disease-Modifying Drugs for Multiple Sclerosis
Neurol 102:e208006, Ng, HS.,et al, 2024